15.03.360 General Requirements

(a) Medical marijuana products produced by a registered entity shall be examined in a laboratory approved for the analysis of medical marijuana by the Authority.

(b) No Advisory Board member, officer, manager, owner, partner, principal stakeholder or member of a registered entity, or such persons' immediate family member, shall have an interest or voting rights in the laboratory performing medical marijuana testing.

(c) For final product testing, the registered entity shall submit to the laboratory a statistically significant number of samples containing the final medical marijuana product equivalent to the sealed medical marijuana product dispensed to the patient (e.g., liquid extract in a sealed bottle or intact sealed bottle of capsules). Upon prior written approval of the Authority, a registered entity may submit to the laboratory the final medical marijuana product sample packaged in a quantity less than that which would be provided to the patient if the sample is prepared and packaged in the identical manner as the product provided to the patient.

(d) Testing of the final medical marijuana product is mandatory. However, at the option of the registered entity, testing may be performed on components used for the production of the final medical marijuana product including but not limited to water or growing materials. Testing may also be performed on the final marijuana extract e.g. for cannabinoid profile verification or contaminant testing.